DOSSIER · 13F-HR · Q2 2026

Yiheng Capital Management, L.P.

$291M in tracked AUM across 32 positions as of Q2 2026.

YC
CIK 0001447228 · last filed Jun 30, 2026
Total AUM
$291M
as of Q2 2026
Holdings
32
positions
Whale Score
64
64
tracked
Activity
no data
changes this Q
AI Analysis · Q2 2026
Comprehensive Analysis of Yiheng Capital Management, L.P. SEC 13F Filing
1. Portfolio Overview

For the reporting period ending September 30, 2025, Yiheng Capital Management, L.P. executed a significant portfolio restructuring, resulting in a marked reduction in assets under management (AUM). The total portfolio value contracted by 47.5%, declining from $1.11 billion to $583.55 million. This reduction was driven not solely by market performance but by substantial capital reallo...

The portfolio remains highly concentrated, consisting of only 20 holdings. The strategy appears to have shifted from a broader diversified approach to a "barbell" style, focusing heavily on a few high-conviction names while maintaining smaller positions in specialized growth sectors. The top three holdings—Astera Labs, JD.com, and Noah Holdings—account for approximately 76.8% of the total portfolio value, indicating a high-risk, high-conviction management style.

2. Key Holdings
Analysis generated by 13F Insight from SEC Form 13F filing data · Q2 2026. Methodology

Quarter at a glance — Q2 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q2 2026.

#HoldingValueSharesWeight
01
NOAH
NOAH HLDGS LTD
$67M6.7M23.0%
02
JD
JD.COM INC
$37M599K12.6%
03
BILI
BILIBILI INC
$36M1.5M12.4%
04
EDU
NEW ORIENTAL ED & TECHNOLOGY
$32M538K11.0%
05
HTHT
H WORLD GROUP LTD
$13M323K4.6%
06
HNGE
HINGE HEALTH INC
$13M156K4.5%
07
SVCO
SILVACO GROUP INC
$12M906K4.3%
08
RERE
ATRENEW INC
$12M3.2M4.2%
09
BILL
BILL HOLDINGS INC
$8M223K2.8%
10
VRDN
VIRIDIAN THERAPEUTICS INC
$7M400K2.5%

Filing history

2026Q2Jun 30
$291M 26.3%
32 positionsView →
2026Q1Mar 31
$231M 53.3%
24 positionsView →
2025Q4Dec 31
$494M 15.3%
24 positionsView →
2025Q3Sep 30
$584M 47.5%
20 positionsView →
2025Q2Jun 30
$1.1B 9.5%
25 positionsLocked
2025Q1Mar 31
$1.2B 52.8%
18 positionsLocked
2024Q4Dec 31
$2.6B 33.4%
23 positionsLocked
2024Q3Sep 30
$1.9B 56.9%
19 positionsLocked
2024Q2Jun 30
$1.2B 31.2%
26 positionsLocked
2024Q1Mar 31
$1.8B 4.0%
25 positionsLocked
2023Q4Dec 31
$1.7B 11.6%
23 positionsLocked
2023Q3Sep 30
$2.0B 6.0%
35 positionsLocked
Showing 12 of 40